THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE
PARIPEX INDIAN JOURNAL OF RESEARCH – May 15, 2023
Source: OpenAlex
Summary
Psychoactive substances like psilocybin, MDMA, and Ayahuasca show groundbreaking potential for mental health. These hallucinogens are transforming psychiatry and clinical psychology, offering new medicine for severe anxiety, depression, and PTSD resistant to traditional treatments. Research in Psychedelics and Drug Studies highlights their effectiveness, suggesting how their chemical synthesis and alkaloid nature influence behavior through neurotransmitter receptors. Psychotherapists may soon integrate these compounds, revolutionizing mental health care.
Abstract
The purpose of this review article is to give a summary of the literature on the use of psychedelic drugs, such as psilocybin, LSD, ayahuasca, and MDMA, in the treatment of various mental health conditions, such as depression, anxiety, PTSD, and substance use disorders. This review's main goal is to highlight recent human studies on the use of particular psychedelic drugs, like psilocybin, LSD, MDMA, and ayahuasca, in the treatment of various psychiatric illnesses, such as treatment-resistant depression, post-traumatic stress disorder, end-of-life anxiety, and substance use disorders. There will also be a discussion of the safety and effectiveness as reported from both human and animal studies. Research has shown that psychedelics have the potential to become ground-breaking treatments for mental health disorders that are resistant to traditional therapies.